| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64513a45a1ec12387162284458b34fda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0defa7ae32b8f2e87805fcdb50e2279f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8016a84ce47e8b9e4882caa62a5e1a53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_448b8f84dbe1cdc40cae2e27a1695f1c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-733
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
| filingDate |
2007-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c3114afc58c2eaa763a18df55bd83c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f2f88ecf065ff54fffe848cf15f5147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10896ee8fd411131cee77a5c2928cd3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f0baa5442d6a497e87d1769e464eae6 |
| publicationDate |
2009-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009252672-A1 |
| titleOfInvention |
Nasal delivery of therapeutic agents using tight junction agonists |
| abstract |
The invention relates to a therapeutic composition comprising a therapeutically effective amount of one or more therapeutic agents and a nasal mucosa absorption-enhancing amount of one or more tight junction agonists. The invention further relates to a method of treating a subject comprising intranasally administering the composition of the invention to the subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010172877-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011032003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015077714-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212181-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8481297-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010080909-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10307458-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011056993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016168197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020018705-A1 |
| priorityDate |
2006-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |